Pharmacognosy Res. 2016 Jan-Mar;8(1):66-70. doi: 10.4103/0974-8490.171104.

Antioxidant and Cytotoxic Effect of Barringtonia racemosa and Hibiscus sabdariffa Fruit Extracts in MCF-7 Human Breast Cancer Cell Line.

Pharmacognosy research

Norliyana Amran, Anis Najwa Abdul Rani, Roziahanim Mahmud, Khoo Boon Yin

PMID: 26941539 PMCID: PMC4753763 DOI: 10.4103/0974-8490.171104

Abstract

BACKGROUND: The fruits of Barringtonia racemosa and Hibiscus sabdariffa have been used in the treatment of abscess, ulcer, cough, asthma, and diarrhea as traditional remedy.

OBJECTIVE: This study aims to evaluate cytotoxic effect of B. racemosa and H. sabdariffa methanol fruit extracts toward human breast cancer cell lines (MCF-7) and its antioxidant activities.

MATERIALS AND METHODS: Total antioxidant activities of extracts were assayed using 2,2'-diphenyl-1-picrylhydrazyl radical (DPPH) and β-carotene bleaching assay. Content of phytochemicals, total flavonoid content (TFC), and total phenolic content (TPC) were determined using aluminum chloride colorimetric method and Folin-Ciocalteu's reagent, respectively. Cytotoxic activity in vitro was investigated through 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay.

RESULTS: B. racemosa extract exhibited high antioxidant activities compared to H. sabdariffa methanol fruit extracts in DPPH radical scavenging assay (inhibitory concentration [IC50] 15.26 ± 1.25 μg/mL) and ί-carotene bleaching assay (I% 98.13 ± 1.83%). B. racemosa also showed higher TPC (14.70 ± 1.05 mg gallic acid equivalents [GAE]/g) and TFC (130 ± 1.18 mg quercetin equivalents [QE]/g) compared to H. sabdariffa (3.80 ± 2.13 mg GAE/g and 40.75 ± 1.15 mg QE/g, respectively). In MTT assay, B. racemosa extract also showed a higher cytotoxic activity (IC50 57.61 ± 2.24 μg/mL) compared to H. sabdariffa.

CONCLUSION: The present study indicated that phenolic and flavonoid compounds known for oxidizing activities indicated an important role among the contents of these plants extract. B. racemosa methanol extract have shown potent cytotoxic activity toward MCF-7. Following these promising results, further fractionation of the plant extract is underway to identify important phytochemical bioactives for the development of potential nutraceutical and pharmaceutical use.

SUMMARY: The phenolic and flavonoid compounds were present in B. racemosa and H. sabdariffa methanol extractsB. racemosa methanol extract was found to be potent antioxidant activityB. racemosa methanol extract have shown potent cytotoxic activity (IC50 57.61 ± 2.24 μg/mL) toward MCF-7The phenolic and flavonoid compounds may contribute to the antioxidant and cytotoxic activity of B. racemosa. Abbreviations Used: MCF-7: Human breast cancer cell lines, DMEM: Modified eagle medium, DPPH: 2,2'-diphenyl-1-picrylhydrazyl radical, TPC: Total phenolic content, Na2CO3: Sodium carbonate, GAE: Gallic acid equivalents, TFC: Total flavonoid content, NaNO2: Sodium nitrite, AlCl3: Aluminum chloride, NaOH: Sodium hydroxide, QE: Quercetin equivalents, MTT: 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide, IC50: Inhibitory concentration,

ANOVA: Analysis of variance, DLA: Dalton's lymphoma ascitic.

Keywords: Antioxidant activities; Barringtonia racemosa; Cytotoxic activity; Hibiscus sabdariffa; Phytochemistry

References

1. J Asian Nat Prod Res. 2010 Aug;12(8):639-48 - PubMed
2. BMC Complement Altern Med. 2009 May 22;9:15 - PubMed
3. J Agric Food Chem. 2002 Mar 13;50(6):1379-82 - PubMed
4. Cancer. 2010 Jan 1;116(1):164-76 - PubMed
5. J Immunol Methods. 1983 Dec 16;65(1-2):55-63 - PubMed
6. J Ethnopharmacol. 2002 Oct;82(2-3):223-7 - PubMed
7. Pharmacogn Mag. 2014 Jan;10(37):70-2 - PubMed
8. Sci Pharm. 2010;78(1):33-45 - PubMed
9. Free Radic Biol Med. 2012 Apr 1;52(7):1242-52 - PubMed
10. Chem Biol Interact. 2007 Jan 5;165(1):59-75 - PubMed

Publication Types

• Journal Article